Company Overview of Zafgen, Inc.
Zafgen, Inc., a biopharmaceutical company, develops obesity therapeutics for use in the treatment of obesity and associated co-morbidities. It develops Beloranib, a Methionine Aminopeptidase 2 inhibitor that is being studied for use as a pharmacological alternative to bariatric surgery in the treatment of severe obesity. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Cambridge, MA 02142
Founded in 2005
Key Executives for Zafgen, Inc.
Zafgen, Inc. Key Developments
Similar Private Companies By Industry
|Drug Safety Alliance, Inc.||United States|
|Asahi Kasei Technikrom, Inc||United States|
|Keraplast Technologies Ltd.||United States|
|Freedom Pharmaceuticals, Inc.||United States|
|Formula Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
November 30, 2012
August 13, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Pittsburgh, PA | Research Recruiting AssociationPosted: Apr 10
- Greenfield, IN | Pace Analytical ServicesPosted: May 24
- Lake Forest, IL | AkornPosted: May 25
Sponsored Financial Commentaries
To contact Zafgen, Inc., please visit www.zafgen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.